Literature DB >> 3279808

Receptors for and effects of insulin and IGF-I in rat glomerular mesangial cells.

H J Arnqvist1, B J Ballermann, G L King.   

Abstract

Receptors for and biological effects of insulin and insulin-like growth factor I (IGF-I) were studied in cultured rat renal mesangial cells. Specific binding of 125I-IGF was over 200-fold greater (5.8%/0.2 mg cell protein) than the specific binding of 125I-insulin (0.2%/2 mg cell protein). Fifty percent inhibition of 125I-insulin binding was obtained with 8 x 10(-9) M unlabeled insulin. For 125I-IGF-I, 50% inhibition required 1.8 x 10(-9) M unlabeled IGF-I. 125I-IGF-I was also displaced by IGF-II and insulin but at 10-and 100-fold lower potencies, respectively, than IGF-I. Cross-linking of 125I-insulin and 125I-IGF-I to their receptors, using disuccinimidyl suberate (DSS), and identification of the receptor with sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography showed a band with a molecular mass of 135 kDa, probably corresponding to the alpha-subunit of the insulin receptor and a major band with a molecular mass of 145 kDa for the alpha-subunit of the IGF-I receptor. Both insulin and IGF-I stimulated the incorporation of [3H]thymidine into DNA. A half-maximal effect was obtained at 1.6 x 10(-8) M for insulin and 1.2 x 10(-9) M for IGF-I. No additive effect on DNA synthesis was observed. Insulin at 8 x 10(-10) M increased the accumulation of [14C]glucose in mesangial cells, whereas IGF-I was 10-fold less potent.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3279808     DOI: 10.1152/ajpcell.1988.254.3.C411

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Insulinlike growth factor-1 is a progression factor for human mesangial cells.

Authors:  T Doi; L J Striker; S J Elliot; F G Conti; G E Striker
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

2.  Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. British Association for Pediatric Nephrology.

Authors:  H Maxwell; L Rees
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

3.  Differential modulation of mitogenic and metabolic actions of insulin-like growth factor I in rat glomerular mesangial cells in high glucose culture.

Authors:  R Kikkawa; M Haneda; M Togawa; D Koya; N Kajiwara; Y Shigeta
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

Review 4.  Cellular and molecular pathomechanisms of diabetic nephropathy.

Authors:  F Thaiss; R Stahl
Journal:  Clin Investig       Date:  1993-10

5.  Characterization of hormone-stimulated Na+ transport in a high-resistance clone of the MDCK cell line.

Authors:  B L Blazer-Yost; R D Record; H Oberleithner
Journal:  Pflugers Arch       Date:  1996-08       Impact factor: 3.657

6.  Effect of insulin-like growth factor I infusion on renal hypertrophy in experimental diabetes mellitus in rats.

Authors:  A Flyvbjerg; K E Bornfeldt; H Orskov; H J Arnqvist
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

7.  Renal insulin-like growth factor I and growth hormone receptor binding in experimental diabetes and after unilateral nephrectomy in the rat.

Authors:  S M Marshall; A Flyvbjerg; J Frystyk; L Korsgaard; H Orskov
Journal:  Diabetologia       Date:  1991-09       Impact factor: 10.122

8.  Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells.

Authors:  G Wolf; U Haberstroh; E G Neilson
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

Review 9.  How safe is the treatment of uraemic children with recombinant human growth hormone?

Authors:  B Tönshoff; U Heinrich; O Mehls
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

10.  Beneficial effect of insulin-like growth factor-1 on hypoxemic renal dysfunction in the newborn rabbit.

Authors:  Anne Prévot; Monique Julita; David K Tung; Dolores Mosig
Journal:  Pediatr Nephrol       Date:  2009-01-24       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.